Morita Yosuke | Department Of Clinical Pharmacology Division Of Pathological Sciences Kyoto Pharmaceutical Universit
スポンサーリンク
概要
- Morita Yosukeの詳細を見る
- 同名の論文著者
- Department Of Clinical Pharmacology Division Of Pathological Sciences Kyoto Pharmaceutical Universitの論文著者
関連著者
-
Katamura Maki
AMI-Kyoto Multi-Center Risk Study Group
-
Nakamura T
Second Department Of Internal Medicine Kyoto Prefectural University Of Medicine
-
Kobara Miyuki
Department of Cardiology, Kyoto Prefectural University School of Medicine
-
Katamura Maki
Department Of Cardiology Kyoto Second Red Cross Hospital
-
Nakata Tetsuo
Department Of Cardiovascular Medicine Nantan General Hospital
-
TOBA Hiroe
Department of Clinical Pharmacology, Kyoto Pharmaceutical University
-
Toba Hiroe
Department Of Clinical Pharmacology Division Of Pathological Science Kyoto Pharmaceutical University
-
Kobara Miyuki
Departments Of Cardiovascular Medicine Kyoto Prefectural University School Of Medicine
-
Kobara Miyuki
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
Kobara Miyuki
Department Of Cardiovascular Medicine Kyoto Prefectural University School Of Medicine
-
Morita Yosuke
Department Of Clinical Pharmacology Division Of Pathological Sciences Kyoto Pharmaceutical Universit
-
Kimata Masaki
Department Of Cardiology Kyoto First Red Cross Hospital
-
Nakata Tetsuo
Department Of Cardiovascular Medicine Kyoto Prefectural University Of Medicine
-
Kobara Miyuki
Department Of Cardiology Kyoto First Red Cross Hospital
-
Nakata Tesuo
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
Nakata Tetsuo
Department Of Clinical Pharmacology Division Of Pathological Science Kyoto Pharmaceutical University
-
Sawai Naoki
Department of Clinical Parmacology, Kyoto Pharmaceutical University
-
Morita Yosuke
Department of Clinical Parmacology, Kyoto Pharmaceutical University
-
Morishita Masayuki
Department of Clinical Pharmacology, Division of Pathological Sciences, Kyoto Pharmaceutical Univers
-
Sawai Naoki
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
Morishita Masayuki
Department Of Clinical Pharmacology Division Of Pathological Sciences Kyoto Pharmaceutical Universit
-
Yoshida Mamiko
Department Of Clinical Pharmacology Division Of Pathological Sciences Kyoto Pharmaceutical Universit
-
Yoshimura Akiko
Department of Clinical Parmacology, Kyoto Pharmaceutical University
-
Yoshimura Akiko
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
Nomura Tetsuya
Department Of Cardiovascular Medicine Kyoto Prefectural University School Of Medicine
-
Shimizu Takahiro
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
Miki Shunsuke
Department of Clinical Parmacology, Kyoto Pharmaceutical University
-
Inoue Riyako
Department of Clinical Parmacology, Kyoto Pharmaceutical University
-
Tsukamoto Rie
Department of Clinical Parmacology, Kyoto Pharmaceutical University
-
Miki Shunsuke
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
Tojo Chisato
Department of Clinical Pharmacology, Division of Pathological Sciences, Kyoto Pharmaceutical Univers
-
Morita Yusuke
Department of Clinical Pharmacology, Kyoto Pharmaceutical University
-
Nakashima Kohei
Department of Clinical Pharmacology, Kyoto Pharmaceutical University
-
Tsukamoto Rie
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
Inoue Riyako
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
Shimizu Takahiro
Department Of Cell Physiology National Institute For Physiological Sciences
-
Tojo Chisato
Department Of Clinical Pharmacology Division Of Pathological Sciences Kyoto Pharmaceutical Universit
-
Nakashima Kohei
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
Nakamura Takeshi
Department Of Cardiovascular Medicine Kyoto Prefectural University School Of Medicine
-
Nakamura Takeshi
Kyoto Prefectural University Of Medicine Department Of Cardiology
-
Morita Yusuke
Department Of Applied Chemistry Graduate School Of Engineering Tohoku University
著作論文
- PJ-477 PPARs Ligands Exhibit the Direct Anti-atherosclerotic Effect by Inhibiting ACE Expression in Streptozotocin-induced Diabetic Rat Aorta(Atherosclerosis, basic-5 (H) PJ80,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the
- DPJ-064 Chronic Administration of Recombinant Human Erythropoietin Exhibits Anti-inflammatory and Anti-oxidative Effects in Experimental Diabetic Rat Aorta beyond Hematopoiesis(DPJ11,Cardiovascular Pharmacology (Basic) (H),Digital Poster Session (Japanese
- OJ-109 Chronic Administration of Recombinant Human Erythropoietin Ameliorates Renal Injury in Experimental Diabetic Rats beyond Hematopoiesis(Kidney/Renal circulation(02)(H),Oral Presentation(Japanese),The 72nd Annual Scientific Meeting of the Japanese Ci
- PJ-819 Erythropoietin Exhibits Renoprotective Effects in the Streptozotocin-Induced Diabetic Rats(Kidney/Renal circulation-6, The 71st Annual Scientific Meeting of the Japanese Circulation Society)